Dr. Mikael Dolsten Named to Agilent Board of Directors

Author's Avatar
Sep 23, 2021

Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Mikael Dolsten, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer Inc. has been elected to Agilent’s board of directors, effective Sept. 21, 2021.